A large multi-center study published in Neurology found no significant differences in follow-up care needs between new neurology patients seen virtually and those seen in person during the COVID-19 ...
Ivonescimab (PD-1/VEGF bispecific antibody) combined with HAIC for first-line treatment of unresectable hepatocellular carcinoma (uHCC): A prospective, single-arm phase II study. TACE with or without ...
A landmark multi-center study has found that GLP-1 receptor agonists significantly reduce atrial fibrillation-related events and mortality in patients with obesity and pre-existing AF, independent of ...
This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.